Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Exmceuticals Inc C.EXM

EXMceuticals Inc. is a bio-sciences company that is focused on the production of cannabinoid formulations. The Company operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Bullboard Posts (CSE:EXM)

What's going on folks..?

Hello...anybody out there? How long is this EXM Cease Trade going to last? I just read abt the combined venture with Global Canna...and...
OU812Protocol - August 10, 2022

Cease traded

Didn't file financials on time.  Cmon guys.  Get it together 
Luckierjack2 - January 11, 2021

EXMceuticals is poised to sail through Portugal's gateway

This morning, BNN Bloomberg posted an article on EXMceuticals Inc. (CSE: EXM | FSE: A2PAW2 | OTCQB: EXM) and their new venture in...
UVPGuy - November 5, 2020

RE:P.E. ratio of 0.5?

there's no good news coming from one of their key assets I'm told. No chance imo the forecasts hold water. Value is dated.
Battuta29 - October 17, 2019

P.E. ratio of 0.5?

Their website has a presentation that forecasts CAD$75m profit next year. $13m this year. arket cap CAD$50m? doesn't look right.
fieldreporter - April 3, 2019

EXM Ceuticals

Is this being re-listed today as EXM Ceuticals, the medical cannabis company?
fieldreporter - January 31, 2019